
No. of Pages: 134 | Report Code: TIPRE00027165 | Category: Life Sciences
No. of Pages: 134 | Report Code: TIPRE00027165 | Category: Life Sciences
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Veterinary Vaccines Market – By Vaccine Type
1.3.2 APAC Veterinary Vaccines Market – By Technology
1.3.3 APAC Veterinary Vaccines Market – By Country
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4.1 Overview
4.2 APAC PEST Analysis
4.3 Experts Opinion
5.1 Market Drivers
5.1.1 Escalating Incidences of Zoonotic Diseases
5.1.2 Surging Prevalence of Foodborne Diseases and Infections
5.2 Market Restraints
5.2.1 Stiff Government Rules Related to Usage of Veterinary Vaccines
5.3 Market Opportunities
5.3.1 Market Growth in Untapped Economies
5.4 Future Trends
5.4.1 Burgeoning Awareness of Diagnosis and Treatment of Variety of Infectious Diseases
5.5 Impact Analysis
6.1 APAC Veterinary Vaccines Market Revenue Forecast and Analysis
7.1 Overview
7.2 APAC Veterinary Vaccines Market, By Vaccine Type, 2021 & 2028 (%)
7.3 Livestock Vaccines
7.3.1 Overview
7.3.2 Livestock Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.3.3 Bovine Vaccines
7.3.3.1 Overview
7.3.3.2 Bovine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.3.4 Small Ruminant Vaccines
7.3.4.1 Overview
7.3.4.2 Small Ruminant Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Companion Vaccines
7.4.1 Overview
7.4.2 Companion Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.4.3 Feline Vaccines
7.4.3.1 Overview
7.4.3.2 Feline Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.4.4 Canine Vaccines
7.4.4.1 Canine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.4.5 Other Companion Animal Vaccines
7.4.5.1 Overview
7.4.5.2 Other Companion Animal Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Others:
7.5.1 Overview
7.5.2 Others: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8.1 Overview
8.2 APAC Veterinary Vaccines Market Share by Technology - 2021 & 2028 (%)
8.3 Live Attenuated Vaccines
8.3.1 Overview
8.3.2 Live Attenuated Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
8.4 Inactivated Vaccines
8.4.1 Overview
8.4.2 Inactivated Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
8.5 Toxoid Vaccines
8.5.1 Overview
8.5.2 Toxoid Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
8.6 Recombinant Vaccines
8.6.1 Overview
8.6.2 Recombinant Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)
9.1 APAC: Veterinary Vaccines Market
9.1.1 Overview
9.1.2 APAC: Veterinary Vaccines Market, by Country, 2021 & 2028 (%)
9.1.2.1 China: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.2 China: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.2.1 China: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)
9.1.2.2.1.1 China: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (USD Million)
9.1.2.2.1.2 China: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (USD Million)
9.1.2.2.2 China: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.1.2.3 Japan: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.3.1 Japan: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.3.2 Japan: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)
9.1.2.3.2.1 Japan: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (USD Million)
9.1.2.3.2.2 Japan: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (USD Million)
9.1.2.3.3 Japan: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.1.2.4 India: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.4.1 India: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.4.2 India: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)
9.1.2.4.2.1 India: Veterinary Vaccines Market, By Livestock Vaccines, 2019–2028 (USD Million)
9.1.2.4.2.2 India: Veterinary Vaccines Market, By Companion Vaccines, 2019–2028 (USD Million)
9.1.2.4.3 India: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.1.2.5 Australia: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.5.1 Australia: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.5.2 Australia: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)
9.1.2.5.2.1 Australia: Veterinary Vaccines Market, By Livestock Vaccines, 2019–2028 (USD Million)
9.1.2.5.2.2 Australia: Veterinary Vaccines Market, By Companion Vaccines, 2019–2028 (USD Million)
9.1.2.5.3 Australia: Veterinary Vaccines Market, by Technology , 2019–2028 (USD Million)
9.1.2.6 South Korea: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.6.1 South Korea: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.6.2 South Korea: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)
9.1.2.6.2.1 South Korea: Veterinary Vaccines Market, By Livestock Vaccines, 2019–2028 (USD Million)
9.1.2.6.2.2 South Korea: Veterinary Vaccines Market, By Companion Vaccines, 2019–2028 (USD Million)
9.1.2.6.3 South Korea: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
9.1.2.7 Rest of APAC: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.7.1 Rest of APAC: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.7.2 Rest of APAC: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)
9.1.2.7.2.1 Rest of APAC: Veterinary Vaccines Market, By Livestock Vaccines, 2019–2028 (USD Million)
9.1.2.7.2.2 Rest of APAC: Veterinary Vaccines Market, By Companion Vaccines, 2019–2028 (USD Million)
9.1.2.7.3 Rest of APAC: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)
10.1 APAC: Impact Assessment of COVID-19 Pandemic
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12.1 Boehringer Ingelheim International GmbH
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Zoetis Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Merck & Co., Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Virbac
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 BIOVAC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 NEOGEN Corporation
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Elanco
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 HIPRA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Ceva
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Hester Biosciences Limited
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13.1 About The Insight Partners
13.2 Glossary of Terms
Table 1. APAC Veterinary Vaccines Market – Revenue, and Forecast to 2028 (US$ Million)
Table 2. China: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 3. China Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 4. China Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 5. China Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 6. Japan: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 7. Japan Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 8. Japan Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 9. Japan Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 10. India: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 11. India: Veterinary Vaccines Market, By Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 12. India: Veterinary Vaccines Market, By Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 13. India Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 14. Australia: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 15. Australia: Veterinary Vaccines Market, By Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 16. Australia: Veterinary Vaccines Market, By Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 17. Australia Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 18. South Korea: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 19. South Korea: Veterinary Vaccines Market, By Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 20. South Korea: Veterinary Vaccines Market, By Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 21. South Korea Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of APAC: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of APAC: Veterinary Vaccines Market, By Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 24. Rest of APAC: Veterinary Vaccines Market, By Companion Vaccines– Revenue and Forecast to 2028 (USD Million)
Table 25. Rest of APAC Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)
Table 26. Organic Developments Done by Companies
Table 27. Inorganic Developments Done by Companies
Table 28. Glossary of Terms
Figure 1. APAC Veterinary Vaccines Market Segmentation
Figure 2. APAC Veterinary Vaccines Market, By Country
Figure 3. APAC Veterinary Vaccines Market Overview
Figure 4. Livestock Vaccines Segment Held the Largest Share of the Market in 2021
Figure 5. India is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. APAC: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Impact Analysis of Drivers and Restraints Pertaining to APAC Veterinary Vaccines Market
Figure 9. APAC Veterinary Vaccines Market – Forecast and Analysis to 2028
Figure 10. APAC Veterinary Vaccines Market, By Vaccine Type, 2021 & 2028 (%)
Figure 11. APAC Livestock Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. APAC Bovine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. APAC Small Ruminant Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. APAC Companion Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. APAC Feline Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. APAC Canine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 17. APAC Other Companion Animal Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. APAC Others: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. APAC Veterinary Vaccines Market Share by Technology - 2021 & 2028 (%)
Figure 20. APAC Live Attenuated Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 21. APAC Inactivated Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 22. APAC Toxoid Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 23. APAC Recombinant Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 24. APAC Others: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25. APAC: Veterinary Vaccines Market, by Key Country – Revenue (2021) (USD Million)
Figure 26. APAC: Veterinary Vaccines Market, by Country, 2021 & 2028 (%)
Figure 27. China: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Japan: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. India: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. Australia: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. South Korea: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Rest of APAC: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Impact of COVID-19 Pandemic in APAC Country Markets
If you have any queries about this report or would like further information, please contact us:
North America: +1 646 491 9876
Asia-Pacific: +91 20 6727 8686
Email: info@theinsightpartners.com
All Rights Reserved.
No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher, “The Insight Partners”.